Skip to main content
. 2019 Apr;11(4):1130–1144. doi: 10.21037/jtd.2019.04.40

Table 2. Cumulative incidence estimates for complications by diagnosis (%), 2002−2015.

Complication type Time Overall (n=191) A1ATD (n=42) COPD (n=149) P value
All 90 days 12.16 17.02 10.81 0.139
1 year 18.53 27.65 15.99
5 years 26.26 34.65 24
Airway 90 days 3.71 7.32 2.71 0.048
1 year 4.79 12.27 2.71
5 years 6.03 12.27 4.28
Wound 90 days 1.06 2.44 0.68 0.649
1 year 3.36 2.44 3.60
5 years 4.09 2.44 4.52
All GI 90 days 5.81 4.88 6.08 0.556
1 year 9.30 10.37 9.01
5 years 12.98 16.78 11.90
GI bleed 90 days 2.64 2.44 2.70 0.839
1 year 2.64 2.44 2.70
5 years 4.67 5.48 4.50
All alimentary 90 days 2.64 2.38 2.70 0.705
1 year 2.64 2.38 2.70
5 years 7.33 5.82 7.78
Diverticulitis 90 days 0.52 2.38 0 0.357
1 year 0.52 2.38 0
5 years 1.34 2.38 1.07
Small bowel obstruction 90 days 0 0 0 0.333
1 year 0 0 0
5 years 2.24 0 2.94
Other alimentary 90 days 2.12 0 2.70 0.718
1 year 2.12 0 2.70
5 years 3.75 3.39 3.78
All HPB 90 days 3.70 2.44 4.05 0.452
1 year 7.72 10.37 6.98
5 years 10.10 13.70 9.04
Acute pancreatitis 90 days 2.12 2.44 2.03 0.751
1 year 2.71 2.44 2.79
5 years 3.47 2.44 3.78
Ascites 90 days 0.53 0 0.68 0.326
1 year 1.09 2.65 0.68
5 years 1.09 2.65 0.68
Gallstone disease 90 days 1.06 0 1.35 0.381
1 year 4.52 8.13 3.56
5 years 5.33 8.13 4.62
Cirrhosis 90 days 0 0 0 N/A
1 year 0 0 0
5 years 0 0 0
Other HPB 90 days 0 0 0 0.175
1 year 1.68 2.44 1.44
5 years 2.46 5.72 1.44

“Gallstone disease” includes cholelithiasis, cholecystitis, and choledocholithiasis. “Other alimentary” includes gastric bezoar [1] for A1ATD and colon perforation [3], abdominal compartment syndrome [1], perforated duodenal ulcer [1], and unspecified GI perforation requiring ileostomy [1] for COPD. “Other HPB” includes gastroesophageal varices [1], ruptured hepatic artery aneurysm [1], cholangitis [1], portal hypertension [1], pancreatic duct stricture [1] for A1ATD and non-alcoholic steatohepatitis [1], cholestatic hepatitis [1], and pancreatocolonic fistula [1] for COPD. GI, gastrointestinal; HPB, hepatopancreatobiliary; A1ATD, Alpha-1-antitrypsin deficiency; COPD, chronic obstructive pulmonary disease; N/A, not applicable.